All our
news

Discuss, meet & share

WebinarsPodcasts

Presentation of the half-yearly financial results 2022

21 October 2022
On the occasion of the publication of the half-yearly results 2022, Intrasense will give an update on its latest developments.
Watch the video

Presentation of 2021 annual results and 2022 ambitions

14 March 2022
On the occasion of the release of the 2021 annual results, Intrasense will provide an update on its latest developments.
Watch the video

Demo of the new COVID-19 dedicated protocol

2 April 2020
Intrasense has developed a specific reading protocol based on the pulmonary application XP-Lung of the Myrian platform. This protocol incudes many clinical key points, particularly about screening, analysis of the pathological stages as well as clinical evolutions. The solution developed by Intrasense teams automatically and intuitively provides an objective measurement of the impairment and of […]
Watch the video

Press releases

Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions

11 January 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euros at an issuance price of 0.44 euro per share, representing a premium of 34.15% over the last closing price of the shares of Intrasense (the "Capital Increase").

See the press release

2022-half-year results: continued growth momentum

12 October 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® (the "Group"), today announces its 2022 IFRS Group consolidated half-year financial results.

See the press release

Intrasense signs a historic contract with Brazilian medical technology leader MV

11 October 2022

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina.

See the press release

Intrasense attends the 70th edition of the "Journées Francophones de Radiologie" 

29 September 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, is pleased to announce its participation in the Journées Francophones de Radiologie (JFR). The exhibition will be held at the Palais des Congrès in Paris. The 2022 edition is dedicated to the continuity of care pathways and to "digital health". This international medical imaging congress will gather more than 10,000 visitors between October 7 and 10

See the press release

Intrasense signs a strategic partnership with Nurea

1 June 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, and Nurea, a leading provider of decision support and diagnostic software for vascular diseases, announce the signing of a partnership that will make Nurea's artificial intelligence solution available to clinicians within the
Myrian platform, through the Intrasense AI Hub.

See the press release
1 2 3 18

Our
conferences

AFIB Congress

From 28/09 to 30/09/2022
The Congress of Biomedical Engineers - Lille.
Details

Journées Francophones de Radiologie 2022

From 07/10 to 10/10/2022.
Palais des Congrès - Porte Maillot - Paris.
Details

Do you want to receive our news in real time?

Subscribe